CD44 and breast cancer: Indeed, breast TICs possess a mesenchymal gene expression signature supportive of mesenchymal and stem-like properties observed in breast cancer cells undergoing EMT such as elevated expression of ALDH and CD44 and low expression of CD249,11,29.